|Principal Investigator/ Physician||Rodney Rocconi, MD|
|Protocol No.||NRG GY004|
|Contact Email||MCI Clinical Trials|
Protocol Title: "A Phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in women with recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer."
Clinical Trails.Gov Link: https://www.clinicaltrials.gov/ct2/show/study/NCT02446600?term=NRG-GY004&rank=1&show_locs=Y#locn
© 2018 USA Health